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Overview of LTOT requirement in 2009 (Fig 1)
Total no of pts 
require LTOT, (n= 
27), 28%
Total no of patients  
for 2009 ( n=68), 
72%
Percentage of patients recieving initial ABG services for the PRP 
in 2009.(Fig 2)
Patients did not 
have ABG's at 
baseline (7 COPD, 6 
IPF, I OHVS)
26% (GROUP B, 
n=14)
Patients had ABG's 
at baseline (11 
COPD, 2 IPF)
24% (GROUP A, 
n= 13)
Total no of pts 
require LTOT 
(n=27)   50%
Percentage of patients in PRP on different 
levels of ambulatory oxygen therapy in Group 
A.(Fig 3)-
6 L (n=2), 14%
4 L (n= 5) 36%
RA (n=4)29%
2 L (n=1) 7%
3 L (n=2) 14%
Percentage of patients in PRP on different 
levels of  ambulatory oxygen therapy in Group 
B.(Fig 4)
RA (n=6) 46%
2L(n= 2)15%
3L(n=1) 8%
4L (n=3) 23%
6L (n =1) 8%
Long-term oxygen therapy (LTOT) is an excellent
therapy option that has been proven to improve
survival in chronic obstructive pulmonary disease
(COPD) patients with chronic respiratory failure. It
also promises to reduce the number of
hospitalizations, increase exercise capacity, and
improve health-related quality of life in patients with
COPD. According to the guidelines (NICE 2010), the
benefits of LTOT depend on correction of hypoxemia.
The determination of hypoxia is based on the three
major steps:
1.The arterial blood gases (ABG) measured at rest.
2. A maximal or a sub maximal exercise test (e.g. 6 Min
walk test).
3. A continuous monitoring of SaO2 and PaCO2
overnight.
Pulmonary rehabilitation (PR) in combination with
appropriate oxygen therapy greatly improves the
functional and psychological aspects of an individual
with COPD (Van et al., 2006 and Bardley et al.,
2007). However inappropriate oxygen prescription
could lead to respiratory depression in these patients
(NICE 2010).
Patients enrolled in PRP initially received a thorough assessment of their functional exercise capacity, ABG, overnight
oximetry, pulmonary function test, quality of life and nutritional status.
ExceptABG’s and overnight oximetry all other assessments are reviewed at 2 months and 1 year.
The resting oxygen therapy is determined by ABG and overnight oximetry provided by the respiratory nurses. The
ambulatory oxygen therapy is determined by assessment of functional exercise capacity provided by the respiratory
physiotherapist.
A retrospective audit of LTOT assessment, prescription and follow-up was performed on the patients enrolled in the PRP
in 2009.
The objective of this audit is to evaluate the percentage of patients in a pulmonary rehabilitation
programme (PRP) receiving appropriate LTOT assessment, prescription and follow up.
METHODOLOGY
The assessment for and prescription of LTOT should
include the following recommendations;
1. The measurement of ABG should be performed on
two occasions at least 3 weeks apart in patients who
have a confident diagnosis of COPD and whose
medical condition is stable (NICE 2010).
2. Patients receiving LTOT should be reviewed at least
once per year by practitioners familiar with LTOT
and this review should include pulse oximetry
(NICE 2010).There is strong evidence from Guyatt
and colleagues (2005) who confirmed that
reassessment for LTOT indicated that an appreciable
portion of initially eligible patients were no longer
eligible.
3. The prescription of LTOT should always include
the source of supplemental oxygen (gas or liquid),
method of delivery, duration of use, and flow rate at
rest, during exercise and sleep (Mª Rosa Güell
Rous. 2008)
GUIDELINES AND EVIDENCE
The lack of initial ABG analysis for the Group B and
follow up in both groups was mainly due the following
reasons:
1.Insufficient no of personnel in respiratory care trained to
do ABG analysis.
2. Lack of time for the current personnel to perform ABG
due to other responsibilities.
3. Lack of timely update on the guidelines due to absence
of in service within the respiratory team.
A positive way to keep abreast of the guideline and
deliver a renowned quality of care would be possible if:
a. Both physiotherapist and nurses involved in PRP were
trained to do ABG analysis.
b. Bi-monthly in-service to update on the guidelines and
recent advances in respiratory care with in the
respiratory team.
In sum, this audit demonstrates that we need to improve
our LTOT assessment, prescription and follow up for
patients enrolled in PRP. In future, new initiatives (e.g.
staffing and training) will be required to manage the
LTOT prescription and follow-up for patients in PRP.
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a. Of the 72% of patients enrolled in PRP (2009) only 
24% (Group A) received the initial ABG analysis 
compared to 26% (Group B) not receiving an initial 
ABG analysis (Fig 1 & 2). However both the groups 
received the assessment for ambulatory oxygen 
therapy. The percentage of patients on different levels 
of ambulatory oxygen in their initial assessment is 
shown in Fig 3 and 4.
b. In the follow up period (Fig 5 & 6) there was a huge 
variation in the levels of the ambulatory oxygen in both 
groups whilst none of them received ABG analysis to 
confirm their resting saturation levels.
Percentage of patients in Group B showing variation in 
the ambulatory oxygen in follow up assessments( 2m 
and 1yr) but no ABG's performed.(Fig 6)
6L↓(COPD,n=1)12%
4L↓(COPD, n=1) 13%
RA ⁭ (COPD, n=4)  49%
3L ⁭ (COPD, n= 1) 13%
2L ⁭ (COPD, n=1)13%
Precentage of patients in Group A showing variation in the 
ambulatory oxygen in follow up assessments (2m and 1yr) 
but no ABGs performed.(Fig 5)
RA  ⁭  ( I PF)
2 0 %( n =1)
2 L  ⁭  ( COPD)
2 0 % ( n =1)
3 L  ⁭  ( COPD)
2 0 %( n =1)
4 L ↓ ( COPD)
2 0 %( n =1)
4 L ⁭  ( COPD)
2 0 %( n =1)
